(Q37838234)

24 August 2017

1 reference

title

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms (English)

1 reference

24 August 2017

1 reference

cardiovascular disease

1 reference

Mohamad Navab

1

1 reference

24 August 2017

Srinivasa T Reddy

series ordinal

2

1 reference

24 August 2017

Brian J Van Lenten

series ordinal

3

1 reference

24 August 2017

Alan M Fogelman

series ordinal

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

8 February 2011

1 reference

Nature Reviews Cardiology

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

222-232

1 reference

24 August 2017

4

1 reference

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

24 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Major lipids, apolipoproteins, and risk of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

High density lipoprotein structure-function and role in reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Regulatory factors in steroid hormone biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Revitalizing membrane rafts: new tools and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Cell cholesterol homeostasis: mediation by active cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Oxidized LDL: diversity, patterns of recognition, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Mechanism of prebeta-HDL formation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Double Superhelix Model of High Density Lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Congruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

ABCA1 and ABCG1 protect against oxidative stress-induced macrophage apoptosis during efferocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

HDL is the major lipoprotein carrier of plasma F2-isoprostanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

HDL, lipid peroxidation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The cholesterol controversy is over. Why did it take so long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The metabolism and anti-atherogenic properties of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Inflammation reduces HDL protection against primary cardiac risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Inflammation impairs reverse cholesterol transport in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Assignment of the binding site for haptoglobin on apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Haptoglobin: basic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Anti-inflammatory properties of paraoxonase-1 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The scavenger receptor class B, type I is a primary determinant of paraoxonase-1 association with high-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The double jeopardy of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

HDL-inflammatory index correlates with poor outcome in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Can dysfunctional HDL explain high coronary artery disease risk in South Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Dysfunctional, pro-inflammatory HDL directly upregulates monocyte PDGFRβ, chemotaxis and TNFα production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Recombinant lipoproteins: implications for structure and assembly of native lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

The ABCs of sterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Anti-inflammatory effects of apolipoprotein A-I in the rabbit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2010.222

Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans

31 March 2020

1 reference

12 December 2020

A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids

1 reference

12 December 2020

High density lipoprotein metabolism.

1 reference

12 December 2020

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

1 reference

12 December 2020

Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.

1 reference

12 December 2020

10.1038/NRCARDIO.2010.222

Identifiers

DOI

1 reference

24 August 2017

1 reference